{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:40:20Z","timestamp":1759974020722,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.medmal.2010.06.009","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T05:15:46Z","timestamp":1282194946000},"page":"691-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Salmonella enterica serovar Typhi de sensibilit\u00e9 diminu\u00e9e \u00e0 la ciprofloxacine"],"prefix":"10.1016","volume":"40","author":[{"given":"V.","family":"Gaborieau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.-X.","family":"Weill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Marchou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2010.06.009_bib0005","unstructured":"Centre national de r\u00e9f\u00e9rence des Salmonella. Rapport d\u2019activit\u00e9 annuel 2008. www.pasteur.fr."},{"key":"10.1016\/j.medmal.2010.06.009_bib0010","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0140-6736(92)90635-G","article-title":"Ciprofloxacin and typhoid fever","volume":"339","author":"Rowe","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2010.06.009_bib0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3201\/eid1405.071184","article-title":"Alternatives to Ciprofloxacin use for enteric fever, United Kingdom","volume":"14","author":"Threlfall","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2334-5-49","article-title":"Treatment failure in a typhoid patient infected with nalidixic acid resistant S.\u00a0enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon","volume":"5","author":"Nkemngu","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0025","doi-asserted-by":"crossref","unstructured":"Ochiai RL, Acosta CJ, Danovaro-Holiday MC, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Org 2008;86:241\u2013320. www.who.int\/bulletin.fr.","DOI":"10.2471\/BLT.06.039818"},{"key":"10.1016\/j.medmal.2010.06.009_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2334-4-36","article-title":"Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series","volume":"4","author":"Slinger","year":"2004","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.trstmh.2006.07.005","article-title":"Cases of typhoid fever imported to England, Scotland and Wales (2000-3)","volume":"101","author":"Cooke","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.medmal.2010.06.009_bib0040","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/AAC.01509-07","article-title":"Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicenter retrospective cohort study","volume":"52","author":"Crump","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2010.06.009_bib0045","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/516128","article-title":"Quinolone-resistant Salmonella typhi in Vietnam: molecular basis of resistance and clinical response to treatment","volume":"25","author":"Wain","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2003.12.002","article-title":"Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi","volume":"49","author":"Rupali","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-5-37","article-title":"Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi","volume":"5","author":"Kadhiravan","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0060","first-page":"356","article-title":"Distribution of orally administred azithromycin in various blood compartments","volume":"32","author":"Wildfeuer","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.medmal.2010.06.009_bib0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever on randomized trial in Egypt that included patients with multigrug resistance","volume":"43","author":"Girgis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2010.06.009_bib0070","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever","volume":"44","author":"Chinh","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.medmal.2010.06.009_bib0075","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/317450","article-title":"Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children","volume":"31","author":"Frenck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0080","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/382359","article-title":"Short course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents","volume":"38","author":"Frenck","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.333.7558.78","article-title":"Current concepts in the diagnosis and treatment of typhoid fever","volume":"333","author":"Bhutta","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2010.06.009_bib0090","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2010.06.009_bib0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2010.06.009_bib0100","first-page":"149","article-title":"Efficacy of azithromycin in the treatment of childhood typhoid fever","volume":"16","author":"Islam","year":"2007","journal-title":"Mymensingh Med"},{"key":"10.1016\/j.medmal.2010.06.009_bib0105","unstructured":"Dolecek C, Tran TP, Nguyen NR, et al. A multicenter randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS ONE 2008;3(5):e2188."},{"key":"10.1016\/j.medmal.2010.06.009_bib0110","first-page":"163","article-title":"Azithromycin versus first line antibiotics in the therapeutic management of documented cases of typhoid fever: a meta-analysis","volume":"33","author":"Katrina","year":"2004","journal-title":"Phil J Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2010.06.009_bib0115","doi-asserted-by":"crossref","unstructured":"Effa EE, Burkirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008;[Issue 4].","DOI":"10.1002\/14651858.CD006083.pub2"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X10001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X10001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:09:19Z","timestamp":1759972159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X10001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0399077X10001587"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2010.06.009","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salmonella enterica serovar Typhi de sensibilit\u00e9 diminu\u00e9e \u00e0 la ciprofloxacine","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2010.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}